STAT3 and neoplasm: Activated STAT3 in immune cells in the tumor microenvironment in turn induces immune suppression by augmenting production of immunosuppressive cytokines and factors while inhibiting Th1 immunostimulatory mediators, leading to inhibition of antitumor T cell activity (6).